These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18751431)

  • 1. Influence of valproic acid on outcome of high-grade gliomas in children.
    Masoudi A; Elopre M; Amini E; Nagel ME; Ater JL; Gopalakrishnan V; Wolff JE
    Anticancer Res; 2008; 28(4C):2437-42. PubMed ID: 18751431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of valproic acid on the outcome of glioblastoma multiforme.
    Tsai HC; Wei KC; Tsai CN; Huang YC; Chen PY; Chen SM; Lu YJ; Lee ST
    Br J Neurosurg; 2012 Jun; 26(3):347-54. PubMed ID: 22168970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade astrocytoma in very young children.
    Sanders RP; Kocak M; Burger PC; Merchant TE; Gajjar A; Broniscer A
    Pediatr Blood Cancer; 2007 Dec; 49(7):888-93. PubMed ID: 17554787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience.
    Attenello FJ; Mukherjee D; Datoo G; McGirt MJ; Bohan E; Weingart JD; Olivi A; Quinones-Hinojosa A; Brem H
    Ann Surg Oncol; 2008 Oct; 15(10):2887-93. PubMed ID: 18636295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
    McGirt MJ; Chaichana KL; Attenello FJ; Weingart JD; Than K; Burger PC; Olivi A; Brem H; Quinoñes-Hinojosa A
    Neurosurgery; 2008 Oct; 63(4):700-7; author reply 707-8. PubMed ID: 18981880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article.
    Scheinemann K; Bartels U; Huang A; Hawkins C; Kulkarni AV; Bouffet E; Tabori U
    J Neurosurg Pediatr; 2009 Sep; 4(3):254-61. PubMed ID: 19772410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of a topoisomerase I inhibitor, karenitecin, by the histone deacetylase inhibitor valproic acid in melanoma: translational and phase I/II clinical trial.
    Daud AI; Dawson J; DeConti RC; Bicaku E; Marchion D; Bastien S; Hausheer FA; Lush R; Neuger A; Sullivan DM; Munster PN
    Clin Cancer Res; 2009 Apr; 15(7):2479-87. PubMed ID: 19318485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
    Lahuerta JJ; Mateos MV; Martínez-López J; Rosiñol L; Sureda A; de la Rubia J; García-Laraña J; Martínez-Martínez R; Hernández-García MT; Carrera D; Besalduch J; de Arriba F; Ribera JM; Escoda L; Hernández-Ruiz B; García-Frade J; Rivas-González C; Alegre A; Bladé J; San Miguel JF
    J Clin Oncol; 2008 Dec; 26(35):5775-82. PubMed ID: 19001321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
    Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
    Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of valproic acid on sleep in children with epilepsy.
    Schmitt B; Martin F; Critelli H; Molinari L; Jenni OG
    Epilepsia; 2009 Aug; 50(8):1860-7. PubMed ID: 19453719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of high-precision radiotherapy in patients with brain stem gliomas: results from a difficult-to-treat patient population using fractionated stereotactic radiotherapy.
    Combs SE; Steck I; Schulz-Ertner D; Welzel T; Kulozik AE; Behnisch W; Huber PE; Debus J
    Radiother Oncol; 2009 Apr; 91(1):60-6. PubMed ID: 19285356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock.
    Gonzales ER; Chen H; Munuve RM; Mehrani T; Nadel A; Koustova E
    J Trauma; 2008 Sep; 65(3):554-65. PubMed ID: 18784568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid.
    Wagner S; Csatary CM; Gosztonyi G; Koch HC; Hartmann C; Peters O; Hernáiz-Driever P; Théallier-Janko A; Zintl F; Längler A; Wolff JE; Csatary LK
    APMIS; 2006 Oct; 114(10):731-43. PubMed ID: 17004977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor applicability of estimation method for adults to calculate unbound serum concentrations of valproic acid in epileptic neonates and infants.
    Ueshima S; Aiba T; Ishikawa N; Sato T; Kawasaki H; Kurosaki Y; Ohtsuka Y; Sendo T
    J Clin Pharm Ther; 2009 Aug; 34(4):415-22. PubMed ID: 19583674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
    Reardon DA; Fink KL; Mikkelsen T; Cloughesy TF; O'Neill A; Plotkin S; Glantz M; Ravin P; Raizer JJ; Rich KM; Schiff D; Shapiro WR; Burdette-Radoux S; Dropcho EJ; Wittemer SM; Nippgen J; Picard M; Nabors LB
    J Clin Oncol; 2008 Dec; 26(34):5610-7. PubMed ID: 18981465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
    J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic acid treatment of glioblastoma multiforme in a child.
    Witt O; Schweigerer L; Driever PH; Wolff J; Pekrun A
    Pediatr Blood Cancer; 2004 Aug; 43(2):181. PubMed ID: 15236290
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe bleeding complications during antiepileptic treatment with valproic acid in children.
    Cannizzaro E; Albisetti M; Wohlrab G; Schmugge M
    Neuropediatrics; 2007 Feb; 38(1):42-5. PubMed ID: 17607605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
    Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
    Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.